Skip to content

CRISPR Therapeutics AG

company in Basel, Switzerland

CRSP Nasdaq SEC CIK 1674416

Follow CRISPR Therapeutics Weekly email: filings, results, news

News

6 stories filed under CRISPR Therapeutics, grouped into ongoing threads

Gene therapy

Thread · 3 stories · active today

Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing

Tech 7 h ago

Citizens reiterates CRISPR Therapeutics stock rating on gene therapy data

Markets 24 d ago

CRISPR Therapeutics reports one-year data for gene therapy CTX310

Markets 27 d ago

More coverage

Where Will CRISPR Therapeutics Stock Be in 5 Years?

Markets 16 d ago

CRISPR Therapeutics: CASGEVY Validates The Platform, Strengthening The Acquisition Case

Deals 19 d ago

CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money?

Markets 34 d ago

Next results

NOV2

Q3 2026 results

Monday · estimated from the filing cadence

Profile

Headquarters: ZUG
Founded: 2013
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)
Website: crisprtx.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 6 stories clustered from the RSS aggregator